scispace - formally typeset
T

Takashi Shimada

Researcher at Nippon Medical School

Publications -  218
Citations -  15059

Takashi Shimada is an academic researcher from Nippon Medical School. The author has contributed to research in topics: Genetic enhancement & Gene. The author has an hindex of 50, co-authored 213 publications receiving 14015 citations. Previous affiliations of Takashi Shimada include Kitasato University.

Papers
More filters
Journal ArticleDOI

Klotho converts canonical FGF receptor into a specific receptor for FGF23

TL;DR: It is shown that a previously undescribed receptor conversion by Klotho, a senescence-related molecule, generates the FGF23 receptor, and insights into the diversity and specificity of interactions between FGF and FGF receptors are provided.
Journal ArticleDOI

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis.

TL;DR: FGF‐23 is a potent regulator of the vitamin D and phosphate metabolism and caused a reduction in serum 1,25‐dihydroxyvitamin D by altering the expressions of key enzymes for the vitaminD metabolism followed by hypophosphatemia.
Journal ArticleDOI

Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism

TL;DR: Evidence is presented that FGF23 is a physiological regulator of serum phosphate and 1,25-dihydroxyvitamin D (1,25[OH]2D) by generating FGF 23-null mice, indicating that F GF23 is essential for normal phosphate and vitamin D metabolism.
Journal ArticleDOI

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

TL;DR: It is concluded that overproduction of F GF23 causes TIO, whereas mutations in the FGF23 gene result in autosomal dominant hypophosphatemic rickets possibly by preventing proteolytic cleavage and enhancing biological activity of FGF 23.
Journal ArticleDOI

Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo.

TL;DR: It is concluded that ADHR is caused by hypophosphatemic action of mutant full-length FGF-23 proteins that are resistant to the cleavage between Arg(179) and Ser(180).